Skip to content
Home - Research - Our research news  - Research feature articles    
Our commitment to biotechnology
Catherine M Bonuccelli, Vice President of External Scientific Affairs for AstraZeneca in the USA, was recently appointed member of the board of directors for BIO.Catherine M Bonuccelli at the BIO 2005 conference
Catherine M Bonuccelli at the BIO 2005 conference

Dr Bonuccelli's appointment reflects our commitment to BIO (Biotechnology Industry Organization) and its mission statements:

"Biotechnology researchers expand the boundaries of science to benefit mankind by providing better healthcare, enhanced agriculture, and a cleaner and safer environment. The mission of BIO is to be the champion of biotechnology and the advocate for its member organizations – both large and small."

BIO Board of Directorsopens in a new window
More about Catherine Bonuccelliopens in a new window

Published 12 July 2005

AstraZeneca websites
Search
Quick links
Related articles